Literature DB >> 16487676

DNA motifs associated with aberrant CpG island methylation.

F Alex Feltus1, Eva K Lee, Joseph F Costello, Christoph Plass, Paula M Vertino.   

Abstract

Epigenetic silencing involving the aberrant methylation of promoter region CpG islands is widely recognized as a tumor suppressor silencing mechanism in cancer. However, the molecular pathways underlying aberrant DNA methylation remain elusive. Recently we showed that, on a genome-wide level, CpG island loci differ in their intrinsic susceptibility to aberrant methylation and that this susceptibility can be predicted based on underlying sequence context. These data suggest that there are sequence/structural features that contribute to the protection from or susceptibility to aberrant methylation. Here we use motif elicitation coupled with classification techniques to identify DNA sequence motifs that selectively define methylation-prone or methylation-resistant CpG islands. Motifs common to 28 methylation-prone or 47 methylation-resistant CpG island-containing genomic fragments were determined using the MEME and MAST algorithms (). The five most discriminatory motifs derived from methylation-prone sequences were found to be associated with CpG islands in general and were nonrandomly distributed throughout the genome. In contrast, the eight most discriminatory motifs derived from the methylation-resistant CpG islands were randomly distributed throughout the genome. Interestingly, this latter group tended to associate with Alu and other repetitive sequences. Used together, the frequency of occurrence of these motifs successfully discriminated methylation-prone and methylation-resistant CpG island groups with an accuracy of 87% after 10-fold cross-validation. The motifs identified here are candidate methylation-targeting or methylation-protection DNA sequences.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487676     DOI: 10.1016/j.ygeno.2005.12.016

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  35 in total

1.  Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer.

Authors:  Marcos R H Estécio; Juan Gallegos; Céline Vallot; Ryan J Castoro; Woonbok Chung; Shinji Maegawa; Yasuhiro Oki; Yutaka Kondo; Jaroslav Jelinek; Lanlan Shen; Helge Hartung; Peter D Aplan; Bogdan A Czerniak; Shoudan Liang; Jean-Pierre J Issa
Journal:  Genome Res       Date:  2010-08-17       Impact factor: 9.043

2.  Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity.

Authors:  Marcel W Coolen; Clare Stirzaker; Jenny Z Song; Aaron L Statham; Zena Kassir; Carlos S Moreno; Andrew N Young; Vijay Varma; Terence P Speed; Mark Cowley; Paul Lacaze; Warren Kaplan; Mark D Robinson; Susan J Clark
Journal:  Nat Cell Biol       Date:  2010-02-21       Impact factor: 28.824

Review 3.  Epigenetics and colorectal cancer.

Authors:  Victoria Valinluck Lao; William M Grady
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-18       Impact factor: 46.802

4.  Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA.

Authors:  Meir Shamay; Anita Krithivas; Jun Zhang; S Diane Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

5.  Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping.

Authors:  Pei-Yin Hsu; Hang-Kai Hsu; Gregory A C Singer; Pearlly S Yan; Benjamin A T Rodriguez; Joseph C Liu; Yu-I Weng; Daniel E Deatherage; Zhong Chen; Julia S Pereira; Ricardo Lopez; Jose Russo; Qianben Wang; Coral A Lamartiniere; Kenneth P Nephew; Tim H-M Huang
Journal:  Genome Res       Date:  2010-05-04       Impact factor: 9.043

6.  Stage-specific alterations of DNA methyltransferase expression, DNA hypermethylation, and DNA hypomethylation during prostate cancer progression in the transgenic adenocarcinoma of mouse prostate model.

Authors:  Shannon R Morey Kinney; Dominic J Smiraglia; Smitha R James; Michael T Moser; Barbara A Foster; Adam R Karpf
Journal:  Mol Cancer Res       Date:  2008-07-30       Impact factor: 5.852

7.  HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors.

Authors:  Kalpana Ghoshal; Tasneem Motiwala; Rainer Claus; Pearlly Yan; Huban Kutay; Jharna Datta; Sarmila Majumder; Shoumei Bai; Arnab Majumder; Tim Huang; Christoph Plass; Samson T Jacob
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.752

8.  Epigenetic transgenerational actions of vinclozolin on promoter regions of the sperm epigenome.

Authors:  Carlos Guerrero-Bosagna; Matthew Settles; Ben Lucker; Michael K Skinner
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

9.  Agglomerative epigenetic aberrations are a common event in human breast cancer.

Authors:  Petr Novak; Taylor Jensen; Marc M Oshiro; George S Watts; Christina J Kim; Bernard W Futscher
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

Review 10.  Breast cancer epigenetics: from DNA methylation to microRNAs.

Authors:  Jürgen Veeck; Manel Esteller
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-01-27       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.